These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2069 related items for PubMed ID: 15514088

  • 1. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L, Ahrén B, Edgren G, Degerman E.
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [Abstract] [Full Text] [Related]

  • 2. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G, Malendowicz LK, Neri G, Andreis PG, Ziolkowska A, Gottardo L, Nowak KW, Nussdorfer GG.
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [Abstract] [Full Text] [Related]

  • 3. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D, Anouar Y, Jegou S, Fournier A, Vaudry H.
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [Abstract] [Full Text] [Related]

  • 4. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O, Junicho A, Akashi T, Koizumi K, Matsuda T, Fuse H, Saiki I.
    Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
    [Abstract] [Full Text] [Related]

  • 5. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R.
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [Abstract] [Full Text] [Related]

  • 6. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
    Jamen F, Puech R, Bockaert J, Brabet P, Bertrand G.
    Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
    [Abstract] [Full Text] [Related]

  • 7. Vasoactive intestinal peptide (VIP) stimulates cortisol secretion from the H295 human adrenocortical tumour cell line via VPAC1 receptors.
    Nicol MR, Cobb VJ, Williams BC, Morley SD, Walker SW, Mason JI.
    J Mol Endocrinol; 2004 Jun; 32(3):869-77. PubMed ID: 15171718
    [Abstract] [Full Text] [Related]

  • 8. Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAP.
    Zusev M, Gozes I.
    Regul Pept; 2004 Dec 15; 123(1-3):33-41. PubMed ID: 15518891
    [Abstract] [Full Text] [Related]

  • 9. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptors in human benign hyperplastic prostate.
    Solano RM, Carmena MJ, Carrero I, Cavallaro S, Roman F, Hueso C, Travali S, Lopez-Fraile N, Guijarro LG, Prieto JC.
    Endocrinology; 1996 Jul 15; 137(7):2815-22. PubMed ID: 8770902
    [Abstract] [Full Text] [Related]

  • 10. Cytosolic Ca2+ responses to sub-picomolar and nanomolar PACAP in pancreatic beta-cells are mediated by VPAC2 and PAC1 receptors.
    Yamada H, Watanabe M, Yada T.
    Regul Pept; 2004 Dec 15; 123(1-3):147-53. PubMed ID: 15518905
    [Abstract] [Full Text] [Related]

  • 11. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB, Dejda A, Niewiadomski P, Gozes I, Nowak JZ.
    J Mol Neurosci; 2005 Dec 15; 25(3):215-24. PubMed ID: 15800375
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland.
    Simonneaux V, Kienlen-Campard P, Loeffler JP, Basille M, Gonzalez BJ, Vaudry H, Robberecht P, Pévet P.
    Neuroscience; 1998 Aug 15; 85(3):887-96. PubMed ID: 9639281
    [Abstract] [Full Text] [Related]

  • 13. Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs.
    Rawlings SR, Piuz I, Schlegel W, Bockaert J, Journot L.
    Endocrinology; 1995 May 15; 136(5):2088-98. PubMed ID: 7720658
    [Abstract] [Full Text] [Related]

  • 14. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain.
    Joo KM, Chung YH, Kim MK, Nam RH, Lee BL, Lee KH, Cha CI.
    J Comp Neurol; 2004 Aug 30; 476(4):388-413. PubMed ID: 15282712
    [Abstract] [Full Text] [Related]

  • 15. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles.
    Vaccari S, Latini S, Barberi M, Teti A, Stefanini M, Canipari R.
    J Endocrinol; 2006 Oct 30; 191(1):287-99. PubMed ID: 17065411
    [Abstract] [Full Text] [Related]

  • 16. Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type I astrocytes.
    Grimaldi M, Cavallaro S.
    Eur J Neurosci; 1999 Aug 30; 11(8):2767-72. PubMed ID: 10457173
    [Abstract] [Full Text] [Related]

  • 17. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons.
    Drahushuk K, Connell TD, Higgins D.
    J Neurosci; 2002 Aug 01; 22(15):6560-9. PubMed ID: 12151535
    [Abstract] [Full Text] [Related]

  • 18. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue.
    García-Fernández MO, Collado B, Bodega G, Cortés J, Ruíz-Villaespesa A, Carmena MJ, Prieto JC.
    Gynecol Endocrinol; 2005 Jun 01; 20(6):327-33. PubMed ID: 16019382
    [Abstract] [Full Text] [Related]

  • 19. PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.
    Apostolakis EM, Riherd DN, O'Malley BW.
    Mol Endocrinol; 2005 Nov 01; 19(11):2798-811. PubMed ID: 15976009
    [Abstract] [Full Text] [Related]

  • 20. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies.
    Schulz S, Röcken C, Mawrin C, Weise W, Höllt V, Schulz S.
    Clin Cancer Res; 2004 Dec 15; 10(24):8235-42. PubMed ID: 15623599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 104.